$1.51 Billion is the total value of ARMISTICE CAPITAL, LLC's 66 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ROX | Exit | CASTLE BRANDS INC | $0 | – | -1,000,000 | -100.0% | -0.03% | – |
| ALRN | Exit | AILERON THERAPEUTICS INC | $0 | – | -1,200,000 | -100.0% | -0.05% | – |
| MDGSW | Exit | MEDIGUS LTD*w exp 07/23/202 | $0 | – | -1,285,715 | -100.0% | -0.10% | – |
| PLAY | Exit | DAVE & BUSTERS ENTMT INC | $0 | – | -50,000 | -100.0% | -0.13% | – |
| BIG | Exit | BIG LOTS INC | $0 | – | -75,000 | -100.0% | -0.14% | – |
| ZFGN | Exit | ZAFGEN INC | $0 | – | -2,178,000 | -100.0% | -0.16% | – |
| TPR | Exit | TAPESTRY INC | $0 | – | -100,000 | -100.0% | -0.20% | – |
| EYEG | Exit | EYEGATE PHARMACEUTICALS INC | $0 | – | -17,812,500 | -100.0% | -0.27% | – |
| SBBP | Exit | STRONGBRIDGE BIOPHARMA PLC | $0 | – | -1,580,000 | -100.0% | -0.31% | – |
| SPOT | Exit | SPOTIFY TECHNOLOGY S A | $0 | – | -48,000 | -100.0% | -0.44% | – |
| SKX | Exit | SKECHERS U S A INCcl a | $0 | – | -252,000 | -100.0% | -0.50% | – |
| GOOS | Exit | CANADA GOOSE HOLDINGS INC | $0 | – | -218,000 | -100.0% | -0.53% | – |
| KMX | Exit | CARMAX INC | $0 | – | -110,000 | -100.0% | -0.60% | – |
| JACK | Exit | JACK IN THE BOX INC | $0 | – | -150,000 | -100.0% | -0.77% | – |
| CLLS | Exit | CELLECTIS S Asponsored ads | $0 | – | -800,000 | -100.0% | -0.79% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -100,000 | -100.0% | -0.80% | – |
| PLNT | Exit | PLANET FITNESS INCcl a | $0 | – | -264,000 | -100.0% | -1.21% | – |
| CPRX | Exit | CATALYST PHARMACEUTICALS INC | $0 | – | -5,000,000 | -100.0% | -1.21% | – |
| FIVE | Exit | FIVE BELOW INC | $0 | – | -213,000 | -100.0% | -1.61% | – |
| SJM | Exit | SMUCKER J M CO | $0 | – | -224,000 | -100.0% | -1.63% | – |
| RH | Exit | RH | $0 | – | -224,000 | -100.0% | -1.63% | – |
| BURL | Exit | BURLINGTON STORES INC | $0 | – | -224,000 | -100.0% | -2.40% | – |
| EPC | Exit | EDGEWELL PERS CARE CO | $0 | – | -1,540,000 | -100.0% | -2.62% | – |
| DFRG | Exit | DEL FRISCOS RESTAURANT GROUP | $0 | – | -6,125,000 | -100.0% | -3.07% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.